Clinical Trials on Breast Carcinoma

Total 35912 results

National Cancer Institute (NCI)

Recruiting

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast Carcinoma

United States
University of Southern California
National Cancer Institute (NCI)

Not yet recruiting

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

Breast Carcinoma

United States
Oncology Specialties, Alabama

Terminated

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

Metastatic Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditions

United States
Washington University School of Medicine
United States Department of Defense; Rising Tide Foundation

Active, not recruiting

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Breast Cancer | Breast Carcinoma | Malignant Neoplasm of Breast

United States
wang shusen

Recruiting

Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer

Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

China
M.D. Anderson Cancer Center

Terminated

Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer

Breast Neoplasm | Inflammatory Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Breast Carcinoma | Breast Fibrocystic Change | Benign Breast Neoplasm

United States
Washington University School of Medicine
Pfizer

Completed

Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer

Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast

United States
Wake Forest University Health Sciences
Pfizer; Atrium Health Levine Cancer Institute

Active, not recruiting

Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer

Breast Cancer | Female Breast Carcinoma

United States
Sentara Norfolk General Hospital
George Mason University; Dorothy G. Hoefer Foundation

Completed

Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)

Breast Cancer

United States
Institut Curie

Completed

Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer (CirCé01)

Breast Cancer Ductal Infiltrating Metastatic

France
American Scitech International

Withdrawn

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

Breast Carcinoma

United States
Mayo Clinic

Recruiting

Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Stage I-III Breast Cancer

Early Stage Breast Carcinoma | Chemotherapy-Related Nausea and/or Vomiting

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer

Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | HER2-Positive Breast Carcinoma

United States
Mayo Clinic
Susan G. Komen Breast Cancer Foundation

Completed

Molecular Breast Imaging in Women With Atypia and LCIS

Lobular Carcinoma in Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia

United States
Cascadian Therapeutics Inc.
Celldex Therapeutics

Completed

Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer

Advanced Breast Carcinoma | Advanced Ovarian Carcinoma

United States
Mayo Clinic

Completed

Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

Breast Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Breast Cancer

United States
University of Alabama at Birmingham
Tesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer... and other collaborators

Recruiting

Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer

Metastatic Breast Cancer | HER2 Positive Breast Carcinoma

United States
Sarah Sammons, MD
Daiichi Sankyo

Recruiting

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Breast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Non Small Cell Lung Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Non-Small Cell Lung Carcinoma

United States
Institut Curie
Zionexa

Recruiting

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients (ECLECTIC)

Breast Carcinoma

France
Mayo Clinic

Recruiting

Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy

Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study

Breast Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Trevarx Biomedical, Inc

Recruiting

A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer

Breast Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer

Breast Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care

Breast Carcinoma

United States
Assiut University

Not yet recruiting

Demographic , Clinicopathological Characteristics and Survival of Breast Cancer

Breast Carcinoma
Mayo Clinic
National Cancer Institute (NCI); Susan G. Komen Breast Cancer Foundation

Active, not recruiting

Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue

Breast Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

E-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast Cancer

Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer

Breast Carcinoma

United States
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening (PReVenT)

Breast Carcinoma

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery

Breast Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment

Breast Carcinoma

United States
M.D. Anderson Cancer Center

Completed

Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment

Breast Carcinoma

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer

Breast Carcinoma

United States
M.D. Anderson Cancer Center

Completed

Development of a Patient Decision Aid for Women Considering Breast Reconstruction

Breast Carcinoma

United States
Danish Breast Cancer Cooperative Group
Danish Cancer Society; Danish Center for Interventional Research in Radiation...

Active, not recruiting

Partial Breast Versus Whole Breast Irradiation in Elderly Women Operated on for Early Breast Cancer

Breast Carcinoma

Denmark
Sidney Kimmel Cancer Center at Thomas Jefferson...
National Institutes of Health (NIH)

Terminated

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

Breast Carcinoma
University of Southern California
National Cancer Institute (NCI)

Terminated

Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer

Breast Carcinoma

United States
National University Hospital, Singapore

Unknown

Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

Breast Carcinoma

Singapore
NSABP Foundation Inc
National Cancer Institute (NCI); Southwest Oncology Group; Radiation Therapy...

Completed

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

Breast Cancer

United States, Canada, Ireland, Israel
Queen Mary University of London
Cancer Research UK

Completed

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ (IBIS-II DCIS)

Breast Cancer

France, Switzerland, Ireland, United Kingdom, Italy, Australia, Austria, Belgium, Chile, Germany, Hungary, Malta, Sweden, Turkey
Kyunghee University Medical Center
Catholic Kwandong University

Unknown

Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients

Breast Carcinoma

Korea, Republic of
National Cancer Institute (NCI)

Completed

Collection of Tissue Samples for Study of Multidrug Resistance

Breast Cancer | Breast Carcinoma | Medullary Thyroid Carcinoma

United States
National Cancer Institute (NCI)

Completed

The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

Breast Cancer

United States
Haukeland University Hospital

Active, not recruiting

The p53 Breast Cancer Trial (p53b)

Locally Advanced Breast Cancer | Metastatic Breast Carcinoma

Norway
National Cancer Institute (NCI)

Recruiting

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

Breast Inflammatory Carcinoma

United States, Canada, Puerto Rico
University of Southern California
National Cancer Institute (NCI)

Recruiting

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

Breast Carcinoma

United States

Clinical Trials on Breast Carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations